Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clofarabine Therapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study

NCT07034053 is registered in ClinicalTrials.gov with Ekaterina Laukhtina as lead sponsor.

NCT NCT07034053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07034053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clofarabine Therapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study
Lead sponsor
Ekaterina Laukhtina
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 24, 2023
Completion date
November 30, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced urothelial carcinoma, metastatic urothelial cancer